Business Context and Reporting Period
This Form 6-K filing by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in metadata) covers the period ending February 2, 2023. The registrant is a foreign private issuer headquartered in Cardiff, United Kingdom, with American Depositary Shares (ADS) trading on the NASDAQ Capital Market under the symbol "MTP."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory notification regarding listing compliance rather than a financial results statement.
Material Changes and Listing Status
On January 31, 2023, the Company received a Notification Letter from NASDAQ stating it is not in compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)).
- Deficiency: The closing bid price of the ADS failed to maintain the required $1.00 per share for 30 consecutive business days ending December 14, 2022.
- Current Status: The Notification Letter has no immediate effect on trading; shares continue to trade on the NASDAQ Capital Market.
- Compliance Period: The Company has a grace period of 180 calendar days, expiring July 31, 2023, to regain compliance.
- Requirement to Cure: The closing bid price must meet or exceed $1.00 per share for at least 10 consecutive business days during the Compliance Period.
Outlook, Risks, and Management Commentary
Management intends to monitor the bid price of its Depositary Shares and will consider taking necessary actions to achieve compliance before the expiration of available grace periods. If the Company fails to regain compliance during the initial 180-day period, it may be eligible for an additional 180-day grace period if it satisfies other initial listing standards and provides written notice of its intention to cure. Failure to comply ultimately subjects the Depositary Shares to delisting, at which point the Company may appeal to a hearing panel.
The filing includes standard forward-looking statements cautioning that actual results may differ due to risks including market conditions and the Company's ability to satisfy listing conditions.
Investor Verification Checklist
- Verify the current trading price of Midatech Pharma PLC ADS (MTP) to assess proximity to the $1.00 threshold.
- Monitor future announcements regarding any stock splits or other corporate actions intended to address the bid price deficiency.
- Review the Company's periodic reports (Form 20-F) for financial health metrics not included in this filing.
- Track the timeline for the July 31, 2023, compliance deadline and any potential appeals or second grace period notifications.